Every public signal F4 has attached to this firm, with sources and cross-entity links.
Team Change
Kyp Sirinakis transitioned to Founding Partner, Elizabeth Roper and Peter Finan were promoted to Managing Partner, and Anthony Voveris was promoted to CFO.
RapidPulse closed an oversubscribed $48M Series B, co-led by Medtronic, TechWald Next, and S3 Ventures, with Epidarex participating as an existing investor.
Lario Therapeutics was awarded $2.4M by The Michael J. Fox Foundation and Wellcome to expand its neuronal calcium channel platform across CNS disorders.
Announced the first close of Epidarex Capital IV, LP, securing more than $145 million to back early-stage UK and US life-science and medtech start-ups.